Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future
Uteron Pharma : Research for woman future

2013/01/23 : Watson Acquires Uteron Pharma

Read more


2012/05/2 : Uteron Pharma is contemplating a public offering to finance the (...)

Read more


2012/04/24 : Professor Jean-Michel Foidart has been awarded the Bologne-Lemaire (...)

Read more



Uteron Pharma : Research for woman future

Background

About Odyssea Pharma & Uteron Pharma SPRL

Uteron Pharma sprl is a Research & Development oriented company and a subsidiary of Allergan plc. Allergan plc is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing brand, branded generic, Over-the Counter (OTC) and biosimilar products.

Odyssea Pharma sprl is designated as one of Allergan Centre of Excellence for women’s health delivering product development, GMP manufacturing of Levosert™ hormonal intra-uterine device and quality & regulatory expertise from a custom-designed facility located in Liège, Belgium. 

The company has successfully developed Levosert™ (levonorgestrel-releasing Intra-Uterine Device), and is currently launching it on the world market

 

About Allergan

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.

  • Allergan is an industry leader in Open Science, the Company’s R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development.
  • Our Company’s success is powered by our more than 16,000 global colleagues’ commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right..
  • With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives. 



© 2011 Uteron Pharma - Legal - Privacy policy Designed and Powered by Lusis Communication

Company

Background
History
Location
Contact us

Products

Levosert™
Diafert™

Production

Market

Newsroom

Uteron Pharma : Research for woman future